Company Shanghai MicuRx Pharmaceutical Co., Ltd.

Equities

688373

CNE100005PX4

Pharmaceuticals

End-of-day quote Shanghai S.E. 18:00:00 2024-06-27 EDT 5-day change 1st Jan Change
4.35 CNY +3.82% Intraday chart for Shanghai MicuRx Pharmaceutical Co., Ltd. -3.97% -33.38%

Business Summary

Shanghai MicuRx Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development (R&D) and commercialization of innovative drugs. The Company's antibacterial drug product, contezolid tablets, can be applied to treat infections caused by multidrug-resistant gram-positive bacteria. The Company also has a number of new anti-drug-resistant bacteria, kidney cancer, nephritis drugs and anti-new crown drug pipelines in the preclinical stage, including MRX-4, MRX-5, MRX-7, MRX-15, MRX-17 and others. The Company operates its businesses primarily in the domestic market.

Number of employees: 205

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 655,210,084 277,573,758 ( 42.36 %) 0 42.36 %
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
4.35 CNY
Average target price
6.875 CNY
Spread / Average Target
+58.05%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688373 Stock
  4. Company Shanghai MicuRx Pharmaceutical Co., Ltd.